Merck's November 2025 release restating the 1987 pledge, the 5 billion treatment total and an extension of the donation to 2030.
To date, Merck has donated more than 5 billion Mectizan treatments to 62 countries
Merck's November 2025 release restating the 1987 pledge, the 5 billion treatment total and an extension of the donation to 2030. C7. Company statement, recorded as written. Record fields: 'Merck first pledged in 1987 to provide Mectizan for the treatment of river blindness … for as much as needed, as long as needed'; 'The Mectizan Donation Program was established that same year as an independent body to oversee Merck's donation'; extension announced 2025-11-17 of up to 100 million treatments annually through 2030. Business interest disclosed neutrally: Merck is the donor and the manufacturer of Mectizan. No financial figures for the programme appear in the release. Study type: news.
